These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

865 related articles for article (PubMed ID: 27091932)

  • 21. Modulation of CD47-SIRPα innate immune checkpoint axis with Fc-function detuned anti-CD47 therapeutic antibody.
    Narla RK; Modi H; Bauer D; Abbasian M; Leisten J; Piccotti JR; Kopytek S; Eckelman BP; Deveraux Q; Timmer J; Zhu D; Wong L; Escoubet L; Raymon HK; Hariharan K
    Cancer Immunol Immunother; 2022 Feb; 71(2):473-489. PubMed ID: 34247273
    [TBL] [Abstract][Full Text] [Related]  

  • 22. SIRPα-Antibody Fusion Proteins Selectively Bind and Eliminate Dual Antigen-Expressing Tumor Cells.
    Piccione EC; Juarez S; Tseng S; Liu J; Stafford M; Narayanan C; Wang L; Weiskopf K; Majeti R
    Clin Cancer Res; 2016 Oct; 22(20):5109-5119. PubMed ID: 27126995
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Loss of Cell Surface CD47 Clustering Formation and Binding Avidity to SIRPα Facilitate Apoptotic Cell Clearance by Macrophages.
    Lv Z; Bian Z; Shi L; Niu S; Ha B; Tremblay A; Li L; Zhang X; Paluszynski J; Liu M; Zen K; Liu Y
    J Immunol; 2015 Jul; 195(2):661-71. PubMed ID: 26085683
    [TBL] [Abstract][Full Text] [Related]  

  • 24. ABO blood groups influence macrophage-mediated phagocytosis of Plasmodium falciparum-infected erythrocytes.
    Wolofsky KT; Ayi K; Branch DR; Hult AK; Olsson ML; Liles WC; Cserti-Gazdewich CM; Kain KC
    PLoS Pathog; 2012; 8(10):e1002942. PubMed ID: 23071435
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Role for CD47-SIRPalpha signaling in xenograft rejection by macrophages.
    Ide K; Wang H; Tahara H; Liu J; Wang X; Asahara T; Sykes M; Yang YG; Ohdan H
    Proc Natl Acad Sci U S A; 2007 Mar; 104(12):5062-6. PubMed ID: 17360380
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Enhanced phagocytosis of CD47-deficient red blood cells by splenic macrophages requires SHPS-1.
    Ishikawa-Sekigami T; Kaneko Y; Saito Y; Murata Y; Okazawa H; Ohnishi H; Oldenborg PA; Nojima Y; Matozaki T
    Biochem Biophys Res Commun; 2006 May; 343(4):1197-200. PubMed ID: 16580635
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Functions and molecular mechanisms of the CD47-SIRPalpha signalling pathway.
    Matozaki T; Murata Y; Okazawa H; Ohnishi H
    Trends Cell Biol; 2009 Feb; 19(2):72-80. PubMed ID: 19144521
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Targeting HDAC6 improves anti-CD47 immunotherapy.
    Gracia-Hernandez M; Yende AS; Gajendran N; Alahmadi Z; Li X; Munoz Z; Tan K; Noonepalle S; Shibata M; Villagra A
    J Exp Clin Cancer Res; 2024 Feb; 43(1):60. PubMed ID: 38414061
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Self inhibition of phagocytosis: the affinity of 'marker of self' CD47 for SIRPalpha dictates potency of inhibition but only at low expression levels.
    Tsai RK; Rodriguez PL; Discher DE
    Blood Cells Mol Dis; 2010 Jun; 45(1):67-74. PubMed ID: 20299253
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Development of AO-176, a Next-Generation Humanized Anti-CD47 Antibody with Novel Anticancer Properties and Negligible Red Blood Cell Binding.
    Puro RJ; Bouchlaka MN; Hiebsch RR; Capoccia BJ; Donio MJ; Manning PT; Frazier WA; Karr RW; Pereira DS
    Mol Cancer Ther; 2020 Mar; 19(3):835-846. PubMed ID: 31879362
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Loss of complement regulatory proteins on uninfected erythrocytes in vivax and falciparum malaria anemia.
    Oyong DA; Kenangalem E; Poespoprodjo JR; Beeson JG; Anstey NM; Price RN; Boyle MJ
    JCI Insight; 2018 Nov; 3(22):. PubMed ID: 30429373
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Macrocyclic Peptide-Mediated Blockade of the CD47-SIRPα Interaction as a Potential Cancer Immunotherapy.
    Hazama D; Yin Y; Murata Y; Matsuda M; Okamoto T; Tanaka D; Terasaka N; Zhao J; Sakamoto M; Kakuchi Y; Saito Y; Kotani T; Nishimura Y; Nakagawa A; Suga H; Matozaki T
    Cell Chem Biol; 2020 Sep; 27(9):1181-1191.e7. PubMed ID: 32640189
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Deletion of CD47 from Schwann cells and macrophages hastens myelin disruption/dismantling and scavenging in Schwann cells and augments myelin debris phagocytosis in macrophages.
    Gitik M; Elberg G; Reichert F; Tal M; Rotshenker S
    J Neuroinflammation; 2023 Oct; 20(1):243. PubMed ID: 37872624
    [TBL] [Abstract][Full Text] [Related]  

  • 34. TTI-621 (SIRPαFc): A CD47-Blocking Innate Immune Checkpoint Inhibitor with Broad Antitumor Activity and Minimal Erythrocyte Binding.
    Petrova PS; Viller NN; Wong M; Pang X; Lin GH; Dodge K; Chai V; Chen H; Lee V; House V; Vigo NT; Jin D; Mutukura T; Charbonneau M; Truong T; Viau S; Johnson LD; Linderoth E; Sievers EL; Maleki Vareki S; Figueredo R; Pampillo M; Koropatnick J; Trudel S; Mbong N; Jin L; Wang JC; Uger RA
    Clin Cancer Res; 2017 Feb; 23(4):1068-1079. PubMed ID: 27856600
    [No Abstract]   [Full Text] [Related]  

  • 35. Signal regulatory protein alpha ligation induces macrophage nitric oxide production through JAK/STAT- and phosphatidylinositol 3-kinase/Rac1/NAPDH oxidase/H2O2-dependent pathways.
    Alblas J; Honing H; de Lavalette CR; Brown MH; Dijkstra CD; van den Berg TK
    Mol Cell Biol; 2005 Aug; 25(16):7181-92. PubMed ID: 16055727
    [TBL] [Abstract][Full Text] [Related]  

  • 36. TSP1-CD47-SIRPα signaling facilitates the development of endometriosis by mediating the survival of ectopic endometrium.
    Liu Y; Li M; Wei C; Tang L; Sheng Y; Liu Y; Li D; Ding D; Qiu J; Zhu X
    Am J Reprod Immunol; 2020 Jun; 83(6):e13236. PubMed ID: 32196807
    [TBL] [Abstract][Full Text] [Related]  

  • 37. DSP107 combines inhibition of CD47/SIRPα axis with activation of 4-1BB to trigger anticancer immunity.
    Cendrowicz E; Jacob L; Greenwald S; Tamir A; Pecker I; Tabakman R; Ghantous L; Tamir L; Kahn R; Avichzer J; Aronin A; Amsili S; Zorde-Khvalevsky E; Gozlan Y; Vlaming M; Huls G; van Meerten T; Dranitzki ME; Foley-Comer A; Pereg Y; Peled A; Chajut A; Bremer E
    J Exp Clin Cancer Res; 2022 Mar; 41(1):97. PubMed ID: 35287686
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Blocking the CD47-SIRPα interaction reverses the disease phenotype in a polycythemia vera mouse model.
    Lysenko V; Schürch PM; Tuzlak S; van Wijk NW; Kovtonyuk LV; Becher B; Manz MG; Kreutmair S; Theocharides APA
    Leukemia; 2023 Jun; 37(6):1277-1286. PubMed ID: 37095207
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Dose-dependent inhibitory effect of CD47 in macrophage uptake of IgG-opsonized murine erythrocytes.
    Olsson M; Nilsson A; Oldenborg PA
    Biochem Biophys Res Commun; 2007 Jan; 352(1):193-7. PubMed ID: 17112468
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The Fully human anti-CD47 antibody SRF231 exerts dual-mechanism antitumor activity via engagement of the activating receptor CD32a.
    Peluso MO; Adam A; Armet CM; Zhang L; O'Connor RW; Lee BH; Lake AC; Normant E; Chappel SC; Hill JA; Palombella VJ; Holland PM; Paterson AM
    J Immunother Cancer; 2020 Apr; 8(1):. PubMed ID: 32345627
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 44.